Also trades as: MMEDV (NASDAQ) · $vol 1M
MMED NASDAQ
MiniMed Group, Inc.
1W: +4.9%
1M: -6.6%
3M: +5.8%
YTD: +0.9%
$18.93
+0.27 (+1.45%)
After Hours: $18.30 (-0.63, -3.35%)
Weekly Expected Move ±7.7%
$16
$17
$18
$20
$21
Credit Risk of going bust: not rated Debt: 1.1% of company value Bonds: none of note held by US funds details ▾
Not rated: insufficient price history.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
2 relationships2
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2026-03-09
Earliest Filing
2026-03-09
Latest Filing
partner: 2
Counterparties (Filed by MMED)
2 relationshipsCompanies named in MMED's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Medtronic plc | MDT | partner | Parent company prior to IPO; transferred Diabetes business assets to MiniMed; retains ~90% ownership post-IPO. | 2026-03-09 | View |
| Kangaroo US HoldCo 2, Inc. | — | partner | Indirect subsidiary of Medtronic that merged with MiniMed Group, Inc. in connection with the Separation. | 2026-03-09 | View |
Recent 8-K Filings (11)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-16 | Change in Control; Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-10-13 | Shareholder Vote; Exhibits | View | |
| 2026-09-01 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-08-05 | Officer/Director Change; Exhibits | View | |
| 2026-06-29 | Officer/Director Change; Other Events; Exhibits | View | |
| 2026-06-03 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-05-18 | Officer/Director Change; Exhibits | View | |
| 2026-04-27 | Regulation FD | View | |
| 2026-03-27 | Officer/Director Change | View | |
| 2026-03-25 | Regulation FD | View | |
| 2026-03-09 | Entry into Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Creati | Agreement Acquisition | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR